Utah Medical Products, Inc. (UTMD)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 241.46M |
| Enterprise value | 147.94M |
| Trailing P/E | 14.94 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 4.98 |
| Price/book (mrq) | 1.89 |
| Enterprise value/revenue | 3.02 |
| Enterprise value/EBITDA | 9.12 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.13 |
| 52-week change 3 | -27.55% |
| S&P500 52-week change 3 | 21.33% |
| 52-week high 3 | 100.59 |
| 52-week low 3 | 65.91 |
| 50-day moving average 3 | 69.19 |
| 200-day moving average 3 | 81.20 |
Share statistics
| Avg vol (3-month) 3 | 31.94k |
| Avg vol (10-day) 3 | 23.83k |
| Shares outstanding 5 | 3.59M |
| Implied shares outstanding 6 | 3.59M |
| Float 8 | 3.15M |
| % held by insiders 1 | 6.52% |
| % held by institutions 1 | 71.89% |
| Shares short (15 Apr 2024) 4 | 88.83k |
| Short ratio (15 Apr 2024) 4 | 2.61 |
| Short % of float (15 Apr 2024) 4 | 3.00% |
| Short % of shares outstanding (15 Apr 2024) 4 | 2.48% |
| Shares short (prior month 15 Mar 2024) 4 | 60.53k |
Dividends & splits
| Forward annual dividend rate 4 | 1.2 |
| Forward annual dividend yield 4 | 1.78% |
| Trailing annual dividend rate 3 | 1.19 |
| Trailing annual dividend yield 3 | 1.75% |
| 5-year average dividend yield 4 | 1.25 |
| Payout ratio 4 | 26.43% |
| Dividend date 3 | 03 Apr 2024 |
| Ex-dividend date 4 | 14 Mar 2024 |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 33.39% |
| Operating margin (ttm) | 34.24% |
Management effectiveness
| Return on assets (ttm) | 8.49% |
| Return on equity (ttm) | 13.33% |
Income statement
| Revenue (ttm) | 49.04M |
| Revenue per share (ttm) | 13.53 |
| Quarterly revenue growth (yoy) | -9.40% |
| Gross profit (ttm) | N/A |
| EBITDA | 24.02M |
| Net income avi to common (ttm) | 16.38M |
| Diluted EPS (ttm) | 4.50 |
| Quarterly earnings growth (yoy) | -6.10% |
Balance sheet
| Total cash (mrq) | 93.81M |
| Total cash per share (mrq) | 26.14 |
| Total debt (mrq) | 285k |
| Total debt/equity (mrq) | 0.22% |
| Current ratio (mrq) | 19.57 |
| Book value per share (mrq) | 35.60 |
Cash flow statement
| Operating cash flow (ttm) | N/A |
| Levered free cash flow (ttm) | N/A |
© 2024 Yahoo. All rights reserved.